You are now leaving https://jnjmd-iis-portal.idea-point.com/. This link will take you to a website where our privacy and legal policies do not apply. You are solely responsible for your interactions with that website. Please OK to continue.

Cancel OK
You are now leaving https://jnjmd-iis-portal.idea-point.com/. This link will take you to a website where our privacy and legal policies do not apply. You are solely responsible for your interactions with that website. Please OK to continue.

Cancel OK
You are now leaving https://jnjmd-iis-portal.idea-point.com/. This link will take you to a website where our privacy and legal policies do not apply. You are solely responsible for your interactions with that website. Please OK to continue.

Cancel OK
You are now leaving https://jnjmd-iis-portal.idea-point.com/. This link will take you to a website where our privacy and legal policies do not apply. You are solely responsible for your interactions with that website. Please OK to continue.

Cancel OK

♥

View All Selected

Clear All

WELCOME TO THE INVESTIGATOR PORTAL

INVESTIGATOR INITIATED STUDY (IIS)

The company supports unique, non-duplicative, independent clinical research studies of scientific and business merit with grants providing either funding and/or product(s). Submissions will only be accepted from study personnel. Company personnel may not submit on behalf of the study personnel.

The IIS program mission is to encourage investigators to pursue and publish original research in areas relevant to the company’s business. The IIS committee serves to assure the IIS program meets all applicable ethical, scientific and strategic criteria, including conformance with applicable Johnson & Johnson Family of Companies and regulatory agency requirements.

Results of these studies are usually published in peer-reviewed medical journals and/or presented at local and global medical congresses, to share knowledge with the entire medical community.

To begin the process of submitting your proposal, click on the button below. You will be asked to login to your account or create an account before you can submit detailed information about your proposal. This will streamline management and evaluation of your IIS proposals.

Submit an IIS Request

PRODUCT CONCEPT – NEW PRODUCT IDEA SUBMISSION

The Biosense Webster, Inc. Innovation Alliance is designed to link physicians in the field with our corporate expertise and capabilities to collaborate and bring new products to the marketplace that will advance the treatment of heart rhythm disorders, as well as address challenges with current offerings. To this end, the Biosense Webster, Inc. Innovation Alliance will review and respond to all complete submissions in an effort to discern the most creative, valuable and executable product ideas. We invite you to learn about the Biosense Webster, Inc. Innovation Alliance and submit your product idea today by clicking the Product Concept button below. You will be redirected to our customer innovation page and then will be asked to login to your account or create an account before you can submit detailed information about your new product concept.

Submit a Product Concept

All contents copyright © Biosense Webster, Inc. 2020. This site is published by Biosense Webster, Inc. which is solely responsible for its contents. This website is intended for healthcare professionals globally that recognize/accept English language. For Biosense Webster, Inc. and its affiliates, click here for our Privacy Policy, Legal Notice, and California Health Care Compliance Information. For Cerenovus, click here for our Privacy Policy, Legal Notice, and California Health Care Compliance Information. Third party trademarks used herein are trademarks of their respective owners.

WARNING NOTICE: This Private Web Site is restricted to authorized use by Johnson & Johnson Services, Inc. ("the Company") and their authorized agents for business purpose only. The actual or attempted unauthorized access, use or modification of the website and its contents is strictly prohibited by the Company. Unauthorized users and/or unauthorized use are subject to criminal and/or civil penalties in accordance with applicable domestic and foreign laws. The use of this web site may be monitored and recorded for administrative and security reasons. If such monitoring and/or recording reveal possible evidence of criminal activity, the Companies may provide the monitored evidence of such activity to law enforcement officials. Access to this application from an un-trusted workstation, including, but not limited to, cyber cafes and public kiosks, is prohibited.